Spinach Nanoparticles and Red Light Improved Heart Function in Rats With Heart Failure
Chinese researchers wrapped photosynthetic membranes from spinach in heart-cell coatings to give failing heart muscle a light-powered energy boost. Delivery to humans remains unsolved.

A spinach leaf can turn light into chemical energy. A failing heart cannot. Researchers in China have now moved part of the leaf's energy-making machinery into rat heart cells to test whether borrowed photosynthesis could help an overworked heart. Their spinach-derived nanoparticles, combined with red light, improved pumping function and reduced tissue damage in rats with experimentally induced heart failure.
The team, led by researchers at Union Hospital of Huazhong University of Science and Technology in Wuhan, reported the work in the journal Small. They describe the result as a "biological battery" able to deliver controlled energy output when stimulated with light, and say it could eventually become an add-on treatment aimed at the energy shortage inside weakened heart muscle.
The logic starts with ATP, the molecule that powers cellular work. Heart muscle needs a continuous supply, and most of it comes from mitochondria. In heart failure the mitochondria falter, and the resulting energy deficit worsens the muscle's dysfunction. Plants make ATP with light, using machinery embedded in membranes called thylakoids. The researchers extracted thylakoids from spinach, broke them into nanoscale particles, and wrapped them in membranes taken from heart muscle cells to help them enter heart cells.
In the lab, cultured rat heart cells took up more of the coated particles than the uncoated ones. When red light hit them, the treated cells made more ATP. In cells exposed to a damaging substance, the illuminated particles helped preserve mitochondrial structure and cut the buildup of harmful reactive molecules.
The animal test used four groups of six rats. Surgeons narrowed the rats' aortas so the heart had to pump against greater resistance, which over time causes enlargement and weaker function. Treatment began four weeks after surgery. The team injected particles directly into the heart muscle every three days, and rats in the light group then got 10 minutes of red laser light through the chest.
Ultrasound showed better pumping in rats that received both particles and light than in untreated animals with the same pressure overload. Their hearts also had less scarring and less abnormal enlargement of muscle cells. Rats that got particles without light showed no statistically significant improvement in pumping, so the combination, not the particles alone, produced the benefit.
The study leaves large practical gaps. The membrane coating helped particles enter cultured cells, but the rats got direct injections, so the work did not show that particles given through a vein would reach the heart in useful amounts. Light is another problem. When the researchers laid a 2-millimeter slice of rat chest-wall tissue over cells holding the particles, red light still raised ATP, but less than direct illumination did. Whether enough light could reach a human heart is unresolved, and the plant machinery also lost ATP-making activity during prolonged illumination.
The authors propose gels or patches that could sit on the heart's surface and release particles gradually, reducing the need for repeated injections. Doctors would still have to deliver enough light to keep the borrowed machinery running. For now, the work is a rat study and an early proof that a plant's energy system can be made to work inside mammalian heart cells.





